Placebo, extended-release microspheres

DRUG2 trials

Sponsors

Luye Pharma Group Ltd.

Conditions

Parkinson Disease

Phase 1

A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease

CompletedNCT04045678

Luye Pharma Group Ltd.Parkinson Disease

Start: 2017-10-10End: 2019-06-21Updated: 2020-09-22

A Study of LY03003 in Patients With Early-stage Parkinson's Disease

CompletedNCT04044547

Luye Pharma Group Ltd.Parkinson Disease

Start: 2013-11-22End: 2015-06-11Updated: 2019-08-05